[Propranolol therapy to treat problematic hemangiomas : a new standard therapy makes its debut].
Small hemangiomas sometimes produce large findings. Depending on localization, local therapy is not always possible. According to a case described in the literature, a hemangioma in an infant regressed following cardiologically indicated Propranolol. This experience has been used in numerous other cases since then and Propranolol has been administered for the indication of a hemangioma. Even in cases of very large hemangiomas rapid improvement has been observed; successful results persisted even after discontinuation. Particularly in cases of problematic localisation, such as in the eye area, prompt therapeutic success is important in order to prevent blindness. Relevant studies are in the preparatory phase.
Löffler
H
H
Hautklinik, SLS-Kliniken GmbH, Am Gesundbrunnen 20-26, 74078, Heilbronn, Deutschland. Harald.Loeffler@slk-kliniken.de
Kosel
C
C
Cremer
H
H
Kachel
W
W
D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D005153:Facial Neoplasms / Q000151:congenital / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D006391:Hemangioma / Q000151:congenital / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D056687:Off-Label Use; D011433:Propranolol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D012878:Skin Neoplasms / Q000151:congenital / Q000188:drug therapy*
D000319:Adrenergic beta-Antagonists; D011433:Propranolol